Artal Group’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-303,600
| Closed | -$7.17M | – | 125 |
|
|
2023
Q4 | $7.17M | Buy |
+303,600
| New | +$7.17M | 0.24% | 39 |
|
|
2019
Q2 | – | Sell |
-600,000
| Closed | -$7.97M | – | 114 |
|
|
2019
Q1 | $7.97M | Buy |
600,000
+100,000
| +20% | +$1.33M | 0.33% | 49 |
|
|
2018
Q4 | $3.94M | Sell |
500,000
-300,000
| -38% | -$2.36M | 0.15% | 50 |
|
|
2018
Q3 | $8.86M | Hold |
800,000
| – | – | 0.23% | 38 |
|
|
2018
Q2 | $10.7M | Buy |
800,000
+400,000
| +100% | +$5.37M | 0.23% | 31 |
|
|
2018
Q1 | $5.2M | Buy |
+400,000
| New | +$5.2M | 0.07% | 43 |
|